Literature DB >> 29788878

Cocrystal and its Application in the Field of Active Pharmaceutical Ingredients and Food Ingredients.

Na Wang1, Chuang Xie1,2, Haijiao Lu1, Nannan Guo1, Yajing Lou1, Weiyi Su3, Hongxun Hao1,2.   

Abstract

BACKGROUND: The development of solid drug dosage form and food ingredients is constrained by their low solubility, low dissolution, low bioavailability and poor physicochemical properties. Formation of cocrystal is a novel and promising method to enhance and improve the properties of materials without breaking the covalent bonds.
METHODS: The goal of this review is to summarize the cocrystals and their applications in the field of Active Pharmaceutical Ingredients (APIs) and food ingredients (AFIs), mainly on the effective improvements of APIs' and AFIs' pharmacokinetic, physicochemical and mechanical properties by the formation of cocrystals.
RESULTS: After years of research and development on cocrystals in the area of pharmaceutical and food industries, significant progress has been made. Formation of cocrystal is an efficient method for improving the solubility, dissolution rate, permeability and in vivo bioavailability of APIs and AFIs, as well as for enhancing stability and mechanical properties.
CONCLUSION: Cocrystals exhibit complex structures which can conspicuously affect the physical and chemical properties of original substance, with good clinical performance and outstanding stability during processing and storage. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.org.

Entities:  

Keywords:  AFIs; APIs; Cocrystals; bioavailability; dissolution; permeability; solubility; stability.

Mesh:

Substances:

Year:  2018        PMID: 29788878     DOI: 10.2174/1381612824666180522102732

Source DB:  PubMed          Journal:  Curr Pharm Des        ISSN: 1381-6128            Impact factor:   3.116


  3 in total

1.  Application of 1-Hydroxy-4,5-Dimethyl-Imidazole 3-Oxide as Coformer in Formation of Pharmaceutical Cocrystals.

Authors:  Aneta Wróblewska; Justyna Śniechowska; Sławomir Kaźmierski; Ewelina Wielgus; Grzegorz D Bujacz; Grzegorz Mlostoń; Arkadiusz Chworos; Justyna Suwara; Marek J Potrzebowski
Journal:  Pharmaceutics       Date:  2020-04-15       Impact factor: 6.321

2.  Pharmacokinetic Comparisons of Naringenin and Naringenin-Nicotinamide Cocrystal in Rats by LC-MS/MS.

Authors:  Dan Xu; Gui-Qiu Zhang; Ting-Ting Zhang; Bo Jin; Chen Ma
Journal:  J Anal Methods Chem       Date:  2020-04-01       Impact factor: 2.193

3.  Solubility enhancement of mefenamic acid by inclusion complex with β-cyclodextrin: in silico modelling, formulation, characterisation, and in vitro studies.

Authors:  Dounia Sid; Milad Baitiche; Zineb Elbahri; Ferhat Djerboua; Mokhtar Boutahala; Zouhair Bouaziz; Marc Le Borgne
Journal:  J Enzyme Inhib Med Chem       Date:  2021-12       Impact factor: 5.051

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.